Cargando…

Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus

The ability to predict the conditions under which antibodies protect against viral infection would transform our approach to vaccine development. A more complete understanding is needed of antibody protection against lentivirus infection, as well as the role of mutation in resistance to an antibody...

Descripción completa

Detalles Bibliográficos
Autores principales: Schwartz, Elissa J., Smith?, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494265/
https://www.ncbi.nlm.nih.gov/pubmed/26344625
http://dx.doi.org/10.3390/vaccines2020397
_version_ 1782380056477171712
author Schwartz, Elissa J.
Smith?, Robert J.
author_facet Schwartz, Elissa J.
Smith?, Robert J.
author_sort Schwartz, Elissa J.
collection PubMed
description The ability to predict the conditions under which antibodies protect against viral infection would transform our approach to vaccine development. A more complete understanding is needed of antibody protection against lentivirus infection, as well as the role of mutation in resistance to an antibody vaccine. Recently, an example of antibody-mediated vaccine protection has been shown via passive transfer of neutralizing antibodies before equine infectious anemia virus (EIAV) infection of horses with severe combined immunodeficiency (SCID). Viral dynamic modeling of antibody protection from EIAV infection in SCID horses may lead to insights into the mechanisms of control of infection by antibody vaccination. In this work, such a model is constructed in conjunction with data from EIAV infection of SCID horses to gain insights into multiple strain competition in the presence of antibody control. Conditions are determined under which wild-type infection is eradicated with the antibody vaccine. In addition, a three-strain competition model is considered in which a second mutant strain may coexist with the first mutant strain. The conditions that permit viral escape by the mutant strains are determined, as are the effects of variation in the model parameters. This work extends the current understanding of competition and antibody control in lentiviral infection, which may provide insights into the development of vaccines that stimulate the immune system to control infection effectively.
format Online
Article
Text
id pubmed-4494265
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44942652015-08-31 Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus Schwartz, Elissa J. Smith?, Robert J. Vaccines (Basel) Article The ability to predict the conditions under which antibodies protect against viral infection would transform our approach to vaccine development. A more complete understanding is needed of antibody protection against lentivirus infection, as well as the role of mutation in resistance to an antibody vaccine. Recently, an example of antibody-mediated vaccine protection has been shown via passive transfer of neutralizing antibodies before equine infectious anemia virus (EIAV) infection of horses with severe combined immunodeficiency (SCID). Viral dynamic modeling of antibody protection from EIAV infection in SCID horses may lead to insights into the mechanisms of control of infection by antibody vaccination. In this work, such a model is constructed in conjunction with data from EIAV infection of SCID horses to gain insights into multiple strain competition in the presence of antibody control. Conditions are determined under which wild-type infection is eradicated with the antibody vaccine. In addition, a three-strain competition model is considered in which a second mutant strain may coexist with the first mutant strain. The conditions that permit viral escape by the mutant strains are determined, as are the effects of variation in the model parameters. This work extends the current understanding of competition and antibody control in lentiviral infection, which may provide insights into the development of vaccines that stimulate the immune system to control infection effectively. MDPI 2014-05-27 /pmc/articles/PMC4494265/ /pubmed/26344625 http://dx.doi.org/10.3390/vaccines2020397 Text en © 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).
spellingShingle Article
Schwartz, Elissa J.
Smith?, Robert J.
Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus
title Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus
title_full Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus
title_fullStr Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus
title_full_unstemmed Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus
title_short Identifying the Conditions Under Which Antibodies Protect Against Infection by Equine Infectious Anemia Virus
title_sort identifying the conditions under which antibodies protect against infection by equine infectious anemia virus
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494265/
https://www.ncbi.nlm.nih.gov/pubmed/26344625
http://dx.doi.org/10.3390/vaccines2020397
work_keys_str_mv AT schwartzelissaj identifyingtheconditionsunderwhichantibodiesprotectagainstinfectionbyequineinfectiousanemiavirus
AT smithrobertj identifyingtheconditionsunderwhichantibodiesprotectagainstinfectionbyequineinfectiousanemiavirus